EFFECTS OF HM15211, A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, ON ANTI-INFLAMMATION AND ANTI-FIBROSIS IN TAA-INDUCED MOUSE MODEL OF LIVER INJURY AND FIBROSIS

被引：0

作者：

Kwon, Hyunjoo ^{[1
]}

Kim, Jung Kuk ^{[1
]}

Lee, Jong Suk ^{[1
]}

Kim, Yohan ^{[1
]}

Park, Eun Jin ^{[1
]}

Choi, Jaehyuk ^{[2
]}

Bae, Sung Min ^{[1
]}

Kim, Dae Jin ^{[1
]}

Lee, Sang Hyun ^{[1
]}

Choi, In Young ^{[1
]}

机构：

[1] Hanmi Pharm Co Ltd, Seoul, South Korea

[2] 14 Wiryeseong Daero, Wiryeseong Daero, South Korea

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2453

引用

页码：S716 / S717

页数：2

共 50 条

[21] Anti-fibrotic Potential of a Novel Long-acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Idiopathic Pulmonary Fibrosis
Kim, J.
Kim, W.
Lee, S.
Lee, J.
Kim, J.
Bae, S.
Kim, D.
Lee, S.
Choi, I.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[22] Therapeutic effect of a novel long-acting GLP-1/GIP/glucagon triple agonist (HM15211) in animal models of NASH and fibrosis
Kim, Jung Kuk
Lee, Jong Suk
Jo, Hyo Sang
Kwon, Hyunjoo
Park, Eun Jin
Kim, Dae Jin
Lee, Sang Hyun
Kim, Young Hoon
Choi, In Young
JOURNAL OF HEPATOLOGY, 2020, 73 : S12 - S13
[23] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice
Choi, Jaehyuk
Kim, Jung Kuk
Lee, Seon Myeong
Kwon, Hyunjoo
Lee, Jongsoo
Bae, Sungmin
Kim, Daejin
Choi, In Young
DIABETES, 2020, 69
[24] Neuroprotective effects of HM15211, a novel long-acting GLP-1/GIP/glucagon triple agonist in the neurodegenerative disease models
Kim, J.
Lee, S.
Lee, S. -H.
Jung, S.
Kim, Y.
Choi, I.
Kim, S.
DIABETOLOGIA, 2018, 61 : S84 - S85
[25] Neuroprotective effects of HM15211, a novel long-acting GLP-1/GIP/Glucagon triple agonist in the neurodegenerative disease models
Kim, W.
Kim, J.
Lee, S. -H.
Bae, S.
Choi, I.
Kim, Y.
DIABETOLOGIA, 2019, 62 : S292 - S292
[26] Bone Protective Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in an Animal Model
Lee, Sangdon
Kim, Yu-Yon
Lee, Jong Suk
Lee, Sang Hyun
Kim, Young Hoon
Choi, In Young
Kim, Sun Jin
DIABETES, 2018, 67
[27] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a Dyslipidemia Animal Model
Choi, Jaehyuk
Jo, Hyosang
Kim, Jung Kuk
Lee, Sang Don
Lee, Sang Hyun
Choi, In Young
DIABETES, 2019, 68
[28] Bone protective effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in an animal model
Lee, S.
Kim, Y. -Y.
Lee, J.
Lee, S. -H.
Kim, Y.
Choi, I.
Kim, S.
DIABETOLOGIA, 2018, 61 : S244 - S245
[29] Neuroprotective Effects of HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in the Neurodegenerative Disease Models
Kim, Jeong A.
Lee, Sangdon
Lee, Sang Hyun
Jung, Sung Youb
Kim, Young Hoon
Choi, In Young
Kim, Sun Jin
DIABETES, 2018, 67
[30] Effect of a novel long-acting GLP-1/GIP/glucagon triple agonist (HM15211) in a dyslipidaemia animal models
Jo, H.
Kim, J.
Choi, J.
Lee, S.
Lee, S. -H.
Choi, I.
DIABETOLOGIA, 2019, 62 : S510 - S511

← 1 2 3 4 5 →